Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

Great idea to look at clinicaltrial.gov Tasigna and Sprycel trials (for pts who initially failed Gleevec) to compare how long those trials ran to use as a gauge.

Given there is no approved treatment for pts with the T315I mutation, I believe Ariad will get approval to skip Phase 2, so, the next trial will be the pivotal, Phase 3 registration trial. As far as timing, based on the last cc, I'd say it's only a matter of weeks until we get FDA approval (although the recent pps sure doesn't seem to be reflecting that at the moment)